Wakefield Asset Management L »

Biosante Pharmaceuticals shares owned by Wakefield Asset Management L

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Wakefield Asset Management L from 13F filings

Historical chart of Wakefield Asset Management L investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Wakefield Asset Management L consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Wakefield Asset Management L

Quarter filed Position value Share count Share price at filing
2024-03-31 $979k 14k 69.13
2023-09-30 $717k 12k 58.06
2023-06-30 $941k 18k 53.83

More positions owned by Wakefield Asset Management L

Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr Eafe Value Etf (EFV)
Ishares Core Msci Emkt (IEMG)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
JPMorgan Chase & Co. (JPM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Marathon Petroleum Corp (MPC)
Caterpillar (CAT)
Ishares Tr Rus 1000 Val Etf (IWD)
Paccar (PCAR)
Target Corporation (TGT)
Trane Technologies SHS (TT)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Baker Hughes Company Cl A (BKR)

View all positions for Wakefield Asset Management L

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
Rubric Capital Management
Dimensional Fund Advisors
William Blair Investment Management
Ranger Investment Management
Global Alpha Capital Management
Geode Capital Management
Susquehanna International
Morgan Stanley
Nuveen Asset Management
Ameriprise Financial
Jpmorgan Chase & Co
Kennedy Capital Management
Charles Schwab Investment Management

View all funds holding Biosante Pharmaceuticals